Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 13, 2014
A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancerSteven H Lin, Jing Zhang, Uma Giri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2011
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescenceHeath D Skinner, Vlad C Sandulache, Thomas J Ow, et al.
Molecular Cancer Therapeutics|August 17, 2022
Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and AutophagyMilad Soleimani, Alexander Somma, Tamer Kaoud, et al.
Frontiers in Immunology|September 25, 2023
Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapyNisha Holay, Alexander Somma, Mark Duchow, et al.
Oncotarget|July 8, 2016
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutationsYuehong Wang, Ratnakar Singh, Liguang Wang, et al.
Molecular Therapy. Nucleic Acids|December 17, 2015
In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 RegulationMaria Angelica Cortez, David Valdecanas, Sharareh Niknam, et al.
Nature Computational Science|March 4, 2024
Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics dataDaniel Osorio, Anna Capasso, S Gail Eckhardt, et al.
Cancer Informatics|November 18, 2010
Blasted cell line namesJing Wang, Lauren A Byers, John S Yordy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2017
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung CancerYifan Wang, Jayanthi Gudikote, Uma Giri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2015
KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI VandetanibMonique B Nilsson, Uma Giri, Jayanthi Gudikote, et al.
Pageof 4